Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Abstract Buerger's disease or thromboangiitis obliterans is a type of obstructive vascular diseases categorized as vasculitis and usually present in 95% of young smoker men. The main pathogenetic mechanism is interplay between immune system and inflammation. Earlier our phase II study has shown...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pawan Kumar Gupta, Santanu Dutta, Sanjay Kala, Muralikrishna Nekkanti, Sanjay C. Desai, Subhendu S. Mahapatra, Anita Dhar, Radhakrishnan Raju, Rajkumar M., Arunanshu Behera, Shivashankar P., N.S. Raviraja, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, Prasanth K.V., Jijy Abraham, Hema Boggarapu, K. Udaykumar
Format:	article
Language:	EN
Published:	Wiley 2021
Subjects:	angiogenesis ankle brachial pressure index critical limb ischemia mesenchymal stromal cells rest pain score Rutherford III‐5 or III‐6 Medicine (General) R5-920 Cytology QH573-671
Online Access:	https://doaj.org/article/d9172901775d4f848f334111134a5c7c
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Similar Items